The Nifty Pharma index closed 1.21 per cent up at 21126.75. Benchmark NSE Nifty50 index ended up 414.46 points at 23851.65, ...

Sun Pharma declined 0.93 per cent to Rs 1,689.35. About10 per cent of the Sun Pharma's US specialty revenues is formulated in ...

Aurobindo Pharma jumped 3.42% to Rs 1,119.55 after the pharma company said that it has received final approval from US Food and Drug Administration (USFDA) to manufacture and market Rivaroxaban ...

Aurobindo's manufacturing operations have once again landed the Indian drugmaker in hot water with the U.S. FDA. | ...

Generic Xarelto is a blood thinner medicine that lowers blood clotting. Aurobindo has obtained the Food and Drug ...

Aurobindo Pharma has received final USFDA approval to launch generic Rivaroxaban 2.5mg tablets in the US, targeting a $447 ...

Aurobindo Pharma Ltd ( ($IN:AUROPHARMA) ) has issued an announcement. Aurobindo Pharma Limited has received final approval from the USFDA to ...

Companies like Dr Reddy’s Laboratories, Cipla, Sun Pharmaceutical Industries, and Aurobindo Pharma could see pressure on their margins if tariffs are imposed.

Denosumab works by specifically targeting the RANK ligand (RANKL), a critical protein in the lifecycle of osteoclasts, the ...